HDFC Pharma and Healthcare Fund Regular Growth
EquitySector - Healthcare
17.19
0.10(0.59%)
NAV as on 09 Dec, 2025
CAGR
28.39%
- AUM (Crs.)1,966.73
- Expense Ratio2.08 %
- Sharpe Ratio / Category Average- / 0.94
- Standard Deviation / Category Average- / 16.00
- Beta / Category Average- / 0.96
- Portfolio Turnover / Category Average38.18 / 56.14
- Top 5 Stocks Wt.38.12
- Top 10 Stocks Wt.58.86
- Top 3 Sectors Wt.98.29
- Investment StyleLarge Growth
- Morningstar Rating
Portfolio
Asset Allocation
Weightage by Market Cap
Concentration
- No. of Stocksundefined
- Avg. Market Capundefined
- Top 10 Stocksundefined%
- Top 5 Stocksundefined%
- Top 3 Sectorsundefined%
View Holdings
Fundamentals
| Measures | Fund | Category Average |
|---|
Risk Metrics
Peers
1Y3Y5Y10Y
| Mutual Fund | AUM (cr.) | 3YReturns |
|---|
Holdings
Stocks
Sector
About
- Fund Manager(s)Check HistoryNikhil Mathur, Dhruv Muchhal
- Launch Date04 Oct, 2023
- BenchmarkS&P BSE 500
Objective
To provide long-term capital appreciation by investing predominantly in equity and equity related securities of Pharma and healthcare companies. There is no assurance that the investment objective of the Scheme will be realized.
Riskometer
More Funds From
| Fund Name | Morningstar Rating | AUM (cr.) | 1Y Returns | 3Y Returns | 5Y Returns |
|---|